Baxter Flow Coupler Monitor Devices: Battery Recharge Issues
Baxter recalls 5-size Flow Coupler Monitor devices with potential battery recharge issues. Affected units have specific serial numbers and sizes. No remedy stated in recall.
Lower-risk recall
Potential for the battery to lose its ability to be recharged.
Contact the company
What happened, in plain English
Baxter is recalling Flow Coupler Monitor devices that come in 5 sizes. These implantable medical devices may lose their ability to be recharged, which could affect their function. This recall does not include a remedy. Read more at govinfonow.com/recall/63592-baxter-flow-coupler-monitor-devices-battery-recharge-issues.
Source Summary by GovInfoNow · govinfonow.com/recall/63592-baxter-flow-coupler-monitor-devices-battery-recharge-issues · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0939-2021
Cite this page
“Baxter Flow Coupler Monitor Devices: Battery Recharge Issues.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63592-baxter-flow-coupler-monitor-devices-battery-recharge-issues. Based on FDA recall #Z-0939-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0939-2021%22&limit=1).
Why it’s dangerous
The battery in these devices may lose its ability to be recharged over time. This could lead to the device not functioning properly during medical procedures. However, the recall does not specify how this affects patient safety directly.
Who’s affected
Patients using Baxter Flow Coupler Monitor devices for vascular procedures may be affected. Those with specific serial numbers listed in the recall are most at risk.
How to tell if you have this one
Check if your device has a serial number from the list provided in the recall (e.g., 135306000279 to 139609000610). The device comes in 5 sizes: 2.0 mm, 2.5 mm, 3.0 mm, 3.5 mm, or 4.0 mm.
- Brand
Baxter- Category
Medical device
What to do — step by step
Check Device Serial Number
Look for the serial number on your device to see if it matches the list of affected numbers provided in the recall.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 42 states.
FDA distribution: “Distributed nationwide to AZ, FL, OH, NY, GA, VA, MA, WI, MO, MT, WV, IL, NC, NJ, AR, CA, CO, CT, IA, ID, IN, KS, LA, MD, MI, MN, MS, NE, NH, NM, NV, OK, OR, PA, RI, WY, WA, VT, TX, TN, SC, SD” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.
Recall timeline
FDA published this recall 44 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Baxter recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0939-2021 (December 28, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0939-2021 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.